{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Miami",
      "state": "FL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74519",
      "recalling_firm": "Stratus Pharmaceuticals Inc",
      "address_1": "12379 SW 130th St",
      "address_2": "",
      "postal_code": "33186-6208",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and PR",
      "recall_number": "D-1464-2016",
      "product_description": "Remeven Cream, (50% Urea in a Cream Base), a) 5.0 oz  (142 g) and b) 9.0 oz  (255 g) tubes, Rx only, Manufactured by Sonar Products Inc, Carlstadt, NJ.  Distributed by Stratus Pharmaceuticals Inc., Miami, FL.",
      "product_quantity": "a) 12,345 tubes; b) 8,578 tubes",
      "reason_for_recall": "Crystallization; Complaints that cream appears to have crystallized",
      "recall_initiation_date": "20160526",
      "center_classification_date": "20160823",
      "report_date": "20160831",
      "code_info": "a) Lot (Exp): 8020 (02/17), 8096 (07/18), 8125 (08/18), 8169 (10/18).  NDC 58980-680-50    b) Lot (Exp): 8020 (02/17), 8125 (08/18), 8170 (10/18). NDC 58980-680-90",
      "more_code_info": ""
    }
  ]
}